Significant Inhibition of Corneal Scarring In Vivo with Tissue-Selective, Targeted AAV5 Decorin Gene Therapy
Rajiv R. Mohan(Missouri College), Jonathan Tovey(Harry S. Truman Memorial Veterans' Hospital)
Cited by 90
Related Papers
BMP7 Gene Transfer via Gold Nanoparticles into Stroma Inhibits Corneal Fibrosis In Vivo
|PLoS ONE|2013|119
Targeted AAV5-Smad7 gene therapy inhibits corneal scarring in vivo
|PLoS ONE|2017|80
Epigenetic Reprogramming Via Sodium Butyrate Induces Corneal Myofibroblast Dedifferentiation In Vitro and Inhibits Fibrosis In Vivo
|Investigative Ophthalmology & Visual Science|2025|2
Alterations in Mitochondrial DNA in Corneal Fibroblast and Myofibroblast Post Injury
|Investigative Ophthalmology & Visual Science|2026|1